Beneficial effects of SS-31 peptide on cardiac mitochondrial dysfunction in tafazzin knockdown mice.

Russo, Silvia et al.·Scientific reports·2022·
RPEP-064672022RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Not classified
Evidence
Not graded
Sample
Not reported

What This Study Found

SS-31 improved mitochondrial respiratory capacity in TazKD mice without affecting the MLCL/CL ratio.

Key Numbers

How They Did This

The study used TAFAZZIN knockdown mice to assess the impact of SS-31 on mitochondrial function and lipid profiles.

Why This Research Matters

Improving mitochondrial function could lead to better treatments for Barth Syndrome, a condition with limited therapeutic options. This research highlights the potential of SS-31 as a pharmacological agent.

What This Study Doesn't Tell Us

The study was conducted in mice, and results may not directly translate to humans. Further research is needed to confirm these findings in clinical settings.

Trust & Context

Original Title:
Beneficial effects of SS-31 peptide on cardiac mitochondrial dysfunction in tafazzin knockdown mice.
Published In:
Scientific reports, 12(1), 19847 (2022)
Database ID:
RPEP-06467

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study
What do these levels mean? →

Read More on RethinkPeptides

Related articles coming soon.

Cite This Study

RPEP-06467·https://rethinkpeptides.com/research/RPEP-06467

APA

Russo, Silvia; De Rasmo, Domenico; Signorile, Anna; Corcelli, Angela; Lobasso, Simona. (2022). Beneficial effects of SS-31 peptide on cardiac mitochondrial dysfunction in tafazzin knockdown mice.. Scientific reports, 12(1), 19847. https://doi.org/10.1038/s41598-022-24231-4

MLA

Russo, Silvia, et al. "Beneficial effects of SS-31 peptide on cardiac mitochondrial dysfunction in tafazzin knockdown mice.." Scientific reports, 2022. https://doi.org/10.1038/s41598-022-24231-4

RethinkPeptides

RethinkPeptides Research Database. "Beneficial effects of SS-31 peptide on cardiac mitochondrial..." RPEP-06467. Retrieved from https://rethinkpeptides.com/research/russo-2022-beneficial-effects-of-ss31

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.